U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H13NO3.C4H11NO3
Molecular Weight 376.4037
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KETOROLAC TROMETHAMINE, (S)-

SMILES

NC(CO)(CO)CO.OC(=O)[C@H]1CCN2C1=CC=C2C(=O)C3=CC=CC=C3

InChI

InChIKey=BWHLPLXXIDYSNW-MERQFXBCSA-N
InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2/t11-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C4H11NO3
Molecular Weight 121.135
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C15H13NO3
Molecular Weight 255.2686
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

(S)-ketorolac is the enantiomer of ketorolac, a nonsteroidal anti-inflammatory drug. (S)-ketorolac exhibited potent cyclooxygenase (COX1 and COX2) enzyme inhibition. (S)-ketorolac is considered to be active enantiomer of racemic ketorolac.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.46 µM [IC50]
1.46 µM [IC50]
Conditions

Conditions

PubMed

PubMed

TitleDatePubMed
Absolute configuration of (-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-alpha]pyrrole-1-carboxylic acid, the active enantiomer of ketorolac.
1986 Apr
The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
1994 Jan
Preclinical enantioselective pharmacology of (R)- and (S)- ketorolac.
1998 Feb
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
1999 Feb 15
Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats.
1999 Jul
Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.
2017 Sep

Sample Use Guides

rats: 0.01–1 mg/kg s.c.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:53:33 UTC 2023
Edited
by admin
on Sat Dec 16 10:53:33 UTC 2023
Record UNII
E84R314D35
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KETOROLAC TROMETHAMINE, (S)-
Common Name English
1,3-PROPANEDIOL, 2-AMINO-2-(HYDROXYMETHYL)-, (1S)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLATE (SALT)
Common Name English
1H-PYRROLIZINE-1-CARBOXYLIC ACID, 5-BENZOYL-2,3-DIHYDRO-, (1S)-, COMPD. WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
E84R314D35
Created by admin on Sat Dec 16 10:53:33 UTC 2023 , Edited by admin on Sat Dec 16 10:53:33 UTC 2023
PRIMARY
CAS
156699-13-7
Created by admin on Sat Dec 16 10:53:33 UTC 2023 , Edited by admin on Sat Dec 16 10:53:33 UTC 2023
PRIMARY
PUBCHEM
73416230
Created by admin on Sat Dec 16 10:53:33 UTC 2023 , Edited by admin on Sat Dec 16 10:53:33 UTC 2023
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER